Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).
Product Description:
rlotinib Hydrochlorid
CAS 183319-69-9
| CAS 183319-69-9 | Brand: Renyoung |
| MF C22H23N3O4.HCl | Molecular Weight: 429.90 | |
| Min order: 10grams | ||
| Product Categories: | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fin e Chemicals. | |
| Standard | Purity:≥99% | |
| Appearance | White to off- white crystalline powder | |
| Shelf life | 2 years | |
| Storage | Erlotinib Hydrochlorid should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. | |
COA of Erlotinib hydrochloride:
| Item | Requirements | Test Results |
| Description | Off-white solid | Complies |
| Identification | 1H-NMR | Conforms with standard |
| HPLC Rt | Rt similar to standard | |
| Solubility | Complies | Complies |
| Loss on drying | ≤0.5% | 0.22% |
| Residue on ignition | ≤0.2% | 0.07% |
| Melting point | 223℃~228℃ | 224.8℃-226.2℃ |
| Related substances | ||
| Total impurities | ≤1.0% | 0.33% |
| Any individual impurity |
≤0.5%
|
0.16%
|
| Heavy metal | ≤20ppm | Complies |
| Purity (HPLC) | ≥99.0% | 99.7% |
| Conclusion | Meets the Requirements | |
Packaging &Shipping
1.Packing: 1~1kg/foil bag; 25kg/drum ; 25kg/bag(Different products, different packaging)
2.Shipping:by TNT,FEDEX,DHL UPS,EMS etc
my contact infomation is:
Whatsapp: 008615032102186
Email: bettyapi1989@163.com
Notice: This product is only suitable for laboratory use, or the use of animals. It can not be used directly on the human body

没有评论:
发表评论